Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Amino 1 Butanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116515782A reveals a novel amine dehydrogenase mutant for high-purity chiral amine alcohol production, offering significant cost and safety advantages.
Patent CN110551771A reveals green enzymatic synthesis using 1,3-butanediol. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110551771B details a green enzymatic route for chiral 3-amino-1-butanol. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Novel biocatalytic method for (S)-2-amino-1-butanol and (R)-3-amino-1-butanol using amine dehydrogenases. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Patent CN104961640A reveals a cost-effective rhodium-catalyzed synthesis route for high-purity chiral intermediates, ensuring supply chain stability and safety.
Patent CN115322106B details a novel high-selectivity synthesis route. Achieve cost reduction in pharmaceutical intermediate manufacturing with scalable, mild conditions.